sorbitol has been researched along with Chronic Kidney Diseases in 3 studies
D-glucitol : The D-enantiomer of glucitol (also known as D-sorbitol).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y | 1 |
| Pachori, A | 1 |
| Chen, P | 1 |
| Ma, S | 1 |
| Mendonza, AE | 1 |
| Amer, A | 1 |
| Marbury, TC | 1 |
| Hinder, M | 1 |
| Cerrud-Rodriguez, RC | 1 |
| Alcaraz-Alvarez, D | 1 |
| Chiong, BB | 1 |
| Ahmed, A | 1 |
| Zanoli, L | 1 |
| Granata, A | 1 |
| Lentini, P | 1 |
| Rastelli, S | 1 |
| Fatuzzo, P | 1 |
| Rapisarda, F | 1 |
| Castellino, P | 1 |
1 review available for sorbitol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Sodium-glucose linked transporter-2 inhibitors in chronic kidney disease.
Topics: Animals; Canagliflozin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rat | 2015 |
1 trial available for sorbitol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Glucosuric, renal and haemodynamic effects of licogliflozin, a dual inhibitor of sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2, in patients with chronic kidney disease: A randomized trial.
Topics: Adolescent; Adult; Aged; Anhydrides; Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Glucose; | 2021 |
1 other study available for sorbitol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Vancomycin-resistant
Topics: Aged, 80 and over; Bacteremia; Colitis, Ischemic; Female; Humans; Hypokalemia; Polystyrenes; Renal I | 2017 |